ACE2 News and Research

RSS
Review on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infections

Review on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infections

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Novel machine learning method detects animal coronaviruses that might infect humans

Novel machine learning method detects animal coronaviruses that might infect humans

What is the role of the pediatric gut microbiome in COVID-19?

What is the role of the pediatric gut microbiome in COVID-19?

Research reveals that a viral toxin may contribute to the severity of COVID-19

Research reveals that a viral toxin may contribute to the severity of COVID-19

Polymorphisms in human immunoglobulin heavy chain genes can influence the function of SARS-CoV-2 neutralizing antibodies

Polymorphisms in human immunoglobulin heavy chain genes can influence the function of SARS-CoV-2 neutralizing antibodies

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

How convergent evolution is creating new COVID-19 waves

How convergent evolution is creating new COVID-19 waves

SARS-CoV-1 and SARS-CoV-2 spike proteins utilize different mechanisms to bind to ACE2

SARS-CoV-1 and SARS-CoV-2 spike proteins utilize different mechanisms to bind to ACE2

What is the association between farnesoid X receptor inhibition and protection against COVID-19?

What is the association between farnesoid X receptor inhibition and protection against COVID-19?

Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Study predicts persistent cross-species SARS-CoV-2 variant infectivity

Study predicts persistent cross-species SARS-CoV-2 variant infectivity

Comparison of blood plasma protein expression in mild, moderate, and severe COVID-19 identifies novel disease severity biomarkers

Comparison of blood plasma protein expression in mild, moderate, and severe COVID-19 identifies novel disease severity biomarkers

Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2

Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Novel prefusion S antigen designed by the mutation of the SARS-CoV-2 Spike protein’s trimeric structure

Novel prefusion S antigen designed by the mutation of the SARS-CoV-2 Spike protein’s trimeric structure

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.